Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: A clinical and cost effectiveness modeling study

Vector-Borne and Zoonotic Diseases

Volumn 13, Issue 12, 2013, Pages 877-883

  Lantos, Paul M ^a   Brinkerhoff, R Jory ^b,e   Wormser, Gary P ^c   Clemen, Robert ^d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF RICHMOND   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d DUKE UNIVERSITY   (United States)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Amblyomma americanum; Amoxicillin; Antibiotics; Black legged tick; Borrelia burgdorferi; Cost effectiveness; Decision analysis; Deer tick; Doxycycline; Erythema migrans; Ixodes scapularis; Lone star tick; Lyme borreliosis; Lyme disease; Southern tick associated rash illness (STARI)

Indexed keywords

AMOXICILLIN; DOXYCYCLINE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DRUG COST; ERYTHEMA CHRONICUM MIGRANS; GEOGRAPHY; HUMAN; LYME DISEASE; PRIORITY JOURNAL; SKIN DEFECT; ANIMAL; BORRELIA BURGDORFERI; COST BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT SYSTEM; ECONOMICS; ISOLATION AND PURIFICATION; IXODES; IXODIDAE; PARASITE VECTOR; PATHOLOGY; PHYSIOLOGY; SKIN; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; ARACHNID VECTORS; BORRELIA BURGDORFERI; COST-BENEFIT ANALYSIS; DECISION MAKING; DECISION SUPPORT TECHNIQUES; ERYTHEMA CHRONICUM MIGRANS; GEOGRAPHY; HUMANS; IXODES; IXODIDAE; SKIN; UNITED STATES;

EID: 84889785135     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2013.1365     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention: Incidence by State, 2005-2010. Available at www.cdc.gov/lyme/stats/ chartstables/incidencebystate. html Last accessed July 1, 2012
2. Centers for Disease Control and Prevention: Reported Lyme Disease Cases, U.S., 2010. Available at www.cdc.gov/lyme/ stats/maps/map2010.html Last accessed July 1, 2012
3. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA, et al. Serodiagnosis in early Lyme disease. J Clin Microbiol 1993; 31:3090-3095
4. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005; 18: 484-509
5. Anigstein L, Anigstein D. A review of the evidence in retrospect for a rickettsial etiology in Bullis fever. Tex Rep Biol Med 1975; 33:201-211
6. Campbell BS, Bowles DE. Human tick bite records in a United States Air Force population, 1989-1992: Implications for tickborne disease risk. J Wilderness Med 1994; 5:405-412
7. Campbell GL, Paul WS, Schriefer ME, Craven RB, et al. Epidemiologic and diagnostic studies of patients with suspected early Lyme disease, Missouri, 1990-1993. J Infect Dis 1995; 172:470-480
8. Diuk-Wasser MA, et al. Unpublished data from Diuk-Wasser, et al. 2006
9. Diuk-Wasser MA, Gatewood AG, Cortinas MR, Yaremych-Hamer S, et al. Spatiotemporal patterns of host-seeking Ixodes scapularis nymphs (Acari: Ixodidae) in the United States. J Med Entomol 2006: 43:166-176
10. Diuk-Wasser MA, Hoen AG, Cislo P, Brinkerhoff R, et al. Human risk of infection with Borrelia burgdorferi, the Lyme disease agent, in eastern United States. Am J Trop Med Hyg 2012: 86:320-327
11. Feder HM, Jr., Hoss DM, Zemel L, Telford SR 3rd, et al. Southern tick-Associated rash illness (STARI) in the north: STARI following a tick bite in Long Island, New York. Clin Infect Dis 2011; 53:e142-e146
12. Felz MW, Durden LA, Oliver JH, Jr. Ticks parasitizing humans in Georgia and South Carolina. J Parasitol 1996; 82:505-508
13. Felz MW, Chandler FW, Jr., Oliver JH, Jr., Rahn DW, et al. Solitary erythema migrans in Georgia and South Carolina. Arch Dermatol 1999a; 135:1317-1326
14. Felz MW, Durden LA. Attachment sites of four tick species (Acari: Ixodidae) parasitizing humans in Georgia and South Carolina. J Med Entomol 1999b; 36:361-364
15. Goddard J, McHugh CP. Impact of a severe tick infestation at Little Rock AFB, Arkansas on volant scorpion military training. Mil Med 1990; 155:277-280
16. Hsia EC, Chung JB, Schwartz JS, Albert DA. Cost-effectiveness analysis of the Lyme disease vaccine. Arthritis Rheum 2002; 46:1651-1660
17. Kirkland KB, Klimko TB, Meriwether RA, Schriefer M, et al. Erythema migrans-like rash illness at a camp in North Carolina: A new tick-borne disease? Arch Intern Med 1997; 157:2635-2641
18. Kowalski TJ, Tata S, Berth W, Mathiason MA, et al. Antibiotic treatment duration and long-Term outcomes of patients with early Lyme disease from a Lyme disease-hyperendemic area. Clin Infect Dis 2010; 50:512-520
19. Ledin KE, Zeidner NS, Ribeiro JM, Biggerstaff BJ, et al. Borreliacidal activity of saliva of the tick Amblyomma americanum. Med Vet Entomol 2005; 19:90-95
20. Magid D, Schwartz B, Craft J, Schwartz JS. Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med 1992; 327:534-541
21. Masters EJ, Grigery CN, Masters RW. STARI, or Masters disease: Lone Star tick-vectored Lyme-like illness. Infect Dis Clin North Am 2008; 22:361-376, viii
22. Meltzer MI, Dennis DT, Orloski KA. The cost effectiveness of vaccinating against Lyme disease. Emerg Infect Dis 1999; 5:321-328
23. Merten HA, Durden LA. A state-by-state survey of ticks recorded from humans in the United States. J Vector Ecol 2000; 25:102-113
24. Nichol G, Dennis DT, Steere AC, Lightfoot R, et al. Testtreatment strategies for patients suspected of having Lyme disease: A cost-effectiveness analysis. Ann Intern Med 1998; 128:37-48
25. Pepin KM, Eisen RJ, Mead PS, Piesman J, et al. Geographic variation in the relationship between human Lyme disease incidence and density of infected host-seeking Ixodes scapularis nymphs in the eastern United States. Am J Trop Med Hyg 2012; 86:1062-1071
26. Philipp MT, Masters E, Wormser GP, Hogrefe W, et al. Serologic evaluation of patients from Missouri with erythema migranslike skin lesions with the C6 Lyme test. Clin Vaccine Immunol 2006; 13:1170-1171
27. Piesman J, Happ CM. Ability of the Lyme disease spirochete Borrelia burgdorferi to infect rodents and three species of human-biting ticks (blacklegged tick, American dog tick, lone star tick) (Acari:Ixodidae). J Med Entomol 1997; 34:451-456
28. Ryder JW, Pinger RR, Glancy T. Inability of Ixodes cookei and Amblyomma americanum nymphs (Acari: Ixodidae) to transmit Borrelia burgdorferi. J Med Entomol 1992; 29:525-530
29. Shadick NA, Liang MH, Phillips CB, Fossel K, et al. The costeffectiveness of vaccination against Lyme disease. Arch Intern Med 2001; 161:554-561
30. Sharma A, Jaimungal S, Basdeo-Maharaj K, Chalapathi Rao AV, et al. Erythema migrans-like illness among Caribbean islanders. Emerg Infect Dis 2010; 16:1615-1617
31. Soares CA, Zeidner NS, Beard CB, Dolan MC, et al. Kinetics of Borrelia burgdorferi infection in larvae of refractory and competent tick vectors. J Med Entomol 2006; 43:61-67
32. Tibbles CD, Edlow JA. Does this patient have erythema migrans? JAMA 2007; 297:2617-2627
33. Wormser GP, Ramanathan R, Nowakowski J, McKenna D, et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003; 138:697-704
34. Wormser GP, Masters E, Liveris D, Nowakowski J, et al. Microbiologic evaluation of patients from Missouri with erythema migrans. Clin Infect Dis 2005a; 40:423-428
35. Wormser GP, Masters E, Nowakowski J, McKenna D, et al. Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions. Clin Infect Dis 2005b; 41:958-965
36. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43:1089-1134
37. Zeidner N, Ullmann A, Sackal C, Dolan M, et al. A borreliacidal factor in Amblyomma americanum saliva is associated with phospholipase A2 activity. Exp Parasitol 2009; 121:370-375